Piotr Raubo

1.4k total citations
41 papers, 746 citations indexed

About

Piotr Raubo is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Piotr Raubo has authored 41 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Organic Chemistry, 18 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Piotr Raubo's work include Chemical Synthesis and Analysis (10 papers), Synthetic Organic Chemistry Methods (9 papers) and Synthesis and Catalytic Reactions (7 papers). Piotr Raubo is often cited by papers focused on Chemical Synthesis and Analysis (10 papers), Synthetic Organic Chemistry Methods (9 papers) and Synthesis and Catalytic Reactions (7 papers). Piotr Raubo collaborates with scholars based in United Kingdom, Brazil and Poland. Piotr Raubo's co-authors include Joseph P. A. Harrity, Jerzy Wicha, Philip Kocieński, Wesley J. Moran, Michael Shipman, Robert Narquizian, Christopher R. Smith, Paweł Jankowski, Donna E. Davies and Audrey Richter and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.

In The Last Decade

Piotr Raubo

41 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Piotr Raubo United Kingdom 18 494 316 93 52 43 41 746
C. V. Kavitha India 19 660 1.3× 354 1.1× 56 0.6× 26 0.5× 78 1.8× 40 1.0k
Srinivas Rao Kasibhatla United States 15 393 0.8× 689 2.2× 138 1.5× 44 0.8× 49 1.1× 25 1.1k
Harold V. Meyers United States 13 241 0.5× 262 0.8× 41 0.4× 39 0.8× 57 1.3× 20 595
James E. Sheppeck United States 15 296 0.6× 313 1.0× 53 0.6× 32 0.6× 72 1.7× 24 628
Li‐Hua Huang China 13 252 0.5× 335 1.1× 39 0.4× 18 0.3× 25 0.6× 41 626
S. KLUTCHKO United States 15 624 1.3× 399 1.3× 62 0.7× 23 0.4× 156 3.6× 33 1.0k
Francis G. Fang United States 19 743 1.5× 416 1.3× 70 0.8× 55 1.1× 209 4.9× 38 1.2k
Dina Scarpi Italy 21 784 1.6× 429 1.4× 24 0.3× 102 2.0× 48 1.1× 76 1.1k
Nicolas Inguimbert France 19 299 0.6× 524 1.7× 56 0.6× 35 0.7× 151 3.5× 64 904
Shridhar G. Hegde United States 13 502 1.0× 228 0.7× 25 0.3× 42 0.8× 132 3.1× 21 677

Countries citing papers authored by Piotr Raubo

Since Specialization
Citations

This map shows the geographic impact of Piotr Raubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Raubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Raubo more than expected).

Fields of papers citing papers by Piotr Raubo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Raubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Raubo. The network helps show where Piotr Raubo may publish in the future.

Co-authorship network of co-authors of Piotr Raubo

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Raubo. A scholar is included among the top collaborators of Piotr Raubo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Raubo. Piotr Raubo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilkening, Ina, et al.. (2020). Impact of oxetane incorporation on the structure and stability of alpha-helical peptides. Physical Chemistry Chemical Physics. 22(43). 25075–25083. 1 indexed citations
2.
Raubo, Piotr, Richard H. Evans, & Paul Willis. (2020). The discovery and evaluation of 3-amino-2(1H)-pyrazinones as a novel series of selective p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(18). 127412–127412. 9 indexed citations
3.
Roesner, Stefan, et al.. (2020). Development of oxetane modified building blocks for peptide synthesis. Organic & Biomolecular Chemistry. 18(28). 5400–5405. 10 indexed citations
4.
Raubo, Piotr, et al.. (2017). Solid-Phase Synthesis of Oxetane Modified Peptides. Organic Letters. 19(12). 3303–3306. 23 indexed citations
5.
Sundström, Linda, Monika Sundqvist, Andrea Ahnmark, et al.. (2017). The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1. PLoS ONE. 12(12). e0189060–e0189060. 41 indexed citations
6.
Chappell, Ben, D. Michael Gill, Nathan J. Patmore, et al.. (2016). An iron-catalysed C–C bond-forming spirocyclization cascade providing sustainable access to new 3D heterocyclic frameworks. Nature Chemistry. 9(4). 396–401. 46 indexed citations
7.
Raubo, Piotr, David Andrews, Graeme R. Robb, et al.. (2015). Discovery of potent, selective small molecule inhibitors of α-subtype of type III phosphatidylinositol-4-kinase (PI4KIIIα). Bioorganic & Medicinal Chemistry Letters. 25(16). 3189–3193. 11 indexed citations
8.
Clarkson, Guy J., et al.. (2014). Synthesis and structure of oxetane containing tripeptide motifs. Chemical Communications. 50(63). 8797–8797. 48 indexed citations
9.
Waring, Michael J., Darren A.E. Cross, David Andrews, et al.. (2013). Abstract 2228: Phosphatidylinositol-4-kinase - Potent and selective inhibitors of PI4Kα and PI4Kβ.. Cancer Research. 73(8_Supplement). 2228–2228. 1 indexed citations
10.
Raubo, Piotr, et al.. (2012). Synthesis of 4H-Pyrazino[1,2-a]pyrimidine-4,9(8H)-diones and Imidazo[1,2-a]pyrazin-8(7H)-ones. Synlett. 23(20). 2935–2938. 1 indexed citations
11.
Raubo, Piotr, Claudio Giuliano, Ian T. Huscroft, et al.. (2006). Stereoselective Synthesis of a Potent Human NK1Receptor Antagonist via Acyl-Claisen Rearrangement. Synlett. 600–604. 3 indexed citations
12.
Huscroft, Ian T., Emma Carlson, Gary G. Chicchi, et al.. (2006). 1-Phenyl-8-azabicyclo[3.2.1]octane ethers: A novel series of neurokinin (NK1) antagonists. Bioorganic & Medicinal Chemistry Letters. 16(7). 2008–2012. 18 indexed citations
13.
Raubo, Piotr, et al.. (2005). Development of a Stepwise [3 + 3] Annelation to Functionalized Piperidines. Organic Letters. 7(14). 2993–2996. 37 indexed citations
14.
Duncan, Karen A., Stephen R. Fletcher, Ian T. Huscroft, et al.. (2005). Sarcosine based indandione hGlyT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(5). 1388–1391. 11 indexed citations
15.
Raubo, Piotr, Margaret S. Beer, Peter Hunt, et al.. (2005). Aminoalkyl phenyl sulfones—a novel series of 5-HT7 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 16(5). 1255–1258. 19 indexed citations
16.
Kocieński, Philip, et al.. (1998). A Synthesis of Theopederin D and a Formal Synthesis of Pederin. Synlett. 1998(12). 1432–1434. 15 indexed citations
17.
Kocieński, Philip, et al.. (1996). A synthesis of 18-O-methyl mycalamide B. Journal of the Chemical Society Perkin Transactions 1. 1797–1797. 21 indexed citations
18.
Raubo, Piotr & Jerzy Wicha. (1996). An iterative synthesis of optically-active 1,2-diols using α,β-epoxysilanes as key intermediates. Tetrahedron Asymmetry. 7(3). 763–770. 9 indexed citations
19.
Raubo, Piotr & Jerzy Wicha. (1995). Optically active acylsilanes. Synthesis of selected 2,3-O-isopropylidene-1-(trialkyl/arylsilyl)glyceraldehyde derivatives. Tetrahedron Asymmetry. 6(2). 577–586. 7 indexed citations
20.
Raubo, Piotr & Jerzy Wicha. (1993). Silica Gel Catalyzed Addition of Benzenethiol to α,β-Epoxyalkylsilanes and Epoxides. Synlett. 1993(1). 25–26. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026